Switch theme
Sign up to access all valuation multiples
National Medical Care Co is engaged in the business to establish, own, equip, manage, maintain, and operate healthcare facilities and provide home health care services. The company trades medicines, medical equipment, and supplies in wholesale and retail trade. Geographically, all operations are conducted in the Kingdom of Saudi Arabia. The company generates revenue through the Rendering of clinical services, and the Sale of pharmaceuticals.
2004
n/a
LTM Revenue $376M
LTM EBITDA $109M
$1.9B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
National Medical Care has a last 12-month revenue (LTM) of $376M and a last 12-month EBITDA of $109M.
In the most recent fiscal year, National Medical Care achieved revenue of $345M and an EBITDA of $106M.
National Medical Care expects next 12-month revenue of XXX and NTM EBITDA of XXX
See National Medical Care valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $376M | XXX | $345M | XXX | XXX | XXX |
| Gross Profit | $126M | XXX | $121M | XXX | XXX | XXX |
| Gross Margin | 33% | XXX | 35% | XXX | XXX | XXX |
| EBITDA | $109M | XXX | $106M | XXX | XXX | XXX |
| EBITDA Margin | 29% | XXX | 31% | XXX | XXX | XXX |
| EBIT | $83.0M | XXX | $67.8M | XXX | XXX | XXX |
| EBIT Margin | 22% | XXX | 20% | XXX | XXX | XXX |
| Net Profit | $82.7M | XXX | $79.6M | XXX | XXX | XXX |
| Net Margin | 22% | XXX | 23% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $10.2M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, National Medical Care's stock price is SAR 165 (or $44).
National Medical Care has current market cap of SAR 7.4B (or $2.0B), and EV of SAR 7.2B (or $1.9B).
See National Medical Care trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.9B | $2.0B | XXX | XXX | XXX | XXX | $1.79 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, National Medical Care has market cap of $2.0B and EV of $1.9B.
National Medical Care's trades at 5.5x EV/Revenue multiple, and 18.0x EV/EBITDA.
Equity research analysts estimate National Medical Care's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
National Medical Care has a P/E ratio of 23.8x.
See valuation multiples for National Medical Care and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2.0B | XXX | $2.0B | XXX | XXX | XXX |
| EV (current) | $1.9B | XXX | $1.9B | XXX | XXX | XXX |
| EV/Revenue | 5.1x | XXX | 5.5x | XXX | XXX | XXX |
| EV/EBITDA | 17.5x | XXX | 18.0x | XXX | XXX | XXX |
| EV/EBIT | 23.0x | XXX | 28.2x | XXX | XXX | XXX |
| EV/Gross Profit | 15.2x | XXX | n/a | XXX | XXX | XXX |
| P/E | 23.8x | XXX | 24.7x | XXX | XXX | XXX |
| EV/FCF | 63.4x | XXX | -1088.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialNational Medical Care's last 12 month revenue growth is 16%
National Medical Care's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.
National Medical Care's rule of 40 is 46% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
National Medical Care's rule of X is 70% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for National Medical Care and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 16% | XXX | 16% | XXX | XXX | XXX |
| EBITDA Margin | 29% | XXX | 31% | XXX | XXX | XXX |
| EBITDA Growth | 19% | XXX | 20% | XXX | XXX | XXX |
| Rule of 40 | 46% | XXX | 47% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 70% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 1% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 15% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Athens Medical Centre | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
National Medical Care acquired XXX companies to date.
Last acquisition by National Medical Care was XXXXXXXX, XXXXX XXXXX XXXXXX . National Medical Care acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was National Medical Care founded? | National Medical Care was founded in 2004. |
| Where is National Medical Care headquartered? | National Medical Care is headquartered in Saudi Arabia. |
| Who is the CEO of National Medical Care? | National Medical Care's CEO is Mr. Abdulaziz bin Saleh AlObaid. |
| Is National Medical Care publicy listed? | Yes, National Medical Care is a public company listed on SAU. |
| What is the stock symbol of National Medical Care? | National Medical Care trades under 4005 ticker. |
| When did National Medical Care go public? | National Medical Care went public in 2013. |
| Who are competitors of National Medical Care? | Similar companies to National Medical Care include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
| What is the current market cap of National Medical Care? | National Medical Care's current market cap is $2.0B |
| What is the current revenue of National Medical Care? | National Medical Care's last 12 months revenue is $376M. |
| What is the current revenue growth of National Medical Care? | National Medical Care revenue growth (NTM/LTM) is 16%. |
| What is the current EV/Revenue multiple of National Medical Care? | Current revenue multiple of National Medical Care is 5.1x. |
| Is National Medical Care profitable? | Yes, National Medical Care is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of National Medical Care? | National Medical Care's last 12 months EBITDA is $109M. |
| What is National Medical Care's EBITDA margin? | National Medical Care's last 12 months EBITDA margin is 29%. |
| What is the current EV/EBITDA multiple of National Medical Care? | Current EBITDA multiple of National Medical Care is 17.5x. |
| What is the current FCF of National Medical Care? | National Medical Care's last 12 months FCF is $30.2M. |
| What is National Medical Care's FCF margin? | National Medical Care's last 12 months FCF margin is 8%. |
| What is the current EV/FCF multiple of National Medical Care? | Current FCF multiple of National Medical Care is 63.4x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
